We bring you the latest updates from The Regulatory Review through a simple and fast subscription.
We can deliver your news in your inbox, on your phone or you can read them here on this website on your personal news page.
Unsubscribe at any time without hassle.
The Regulatory Review's title: The Regulatory Review
Is this your feed? Claim it!
The billion-dollar drug development industry depends on data. Before entering the market, a drug must be extensively tested on humans through clinical trials. Researchers
In a supervisory exam or an investigation, oversight begins with a concrete request: show the record for one specific case. For AI-enabled decision workflows, such as, triage, routing, or risk-flagging, what did the workflow receive, what did it produce, who reviewed it, what changed afterward, and what system was in force when the outcome was reached?
Recordkeeping is...
Since the Reagan Administration, agencies have used benefit-cost analysis to determine whether a proposed rule will yield net benef...
In a recent executive order, President Donald J. Trump directed the Attorney General to complete the process of rescheduling marijuana from Schedule 1 to Schedule III under the Controlled Substances Act (CSA). President Trump